This inventor holds 2 USPTO granted patents. Top assignee: American Cyanamid Company. Active years: 1996.
Company Filing History:
Years Active: 1996
Title: The Innovations of Bernard Dubnick
Introduction
Bernard Dubnick is a notable inventor based in Westwood, NJ (US). He has made significant contributions to the field of ophthalmology, particularly in the treatment of glaucoma and ocular hypertension. With a total of 2 patents, Dubnick's work has the potential to improve the quality of life for many patients suffering from these conditions.
Latest Patents
Dubnick's latest patents focus on innovative methods for treating glaucoma. The first patent, titled "Treatment of glaucoma and ocular hypertension with .beta..sub.3," describes a method that involves the topical or systemic administration of a specific compound to reduce intraocular pressure in patients. The second patent, "Treatment of glaucoma and ocular hypertension with .beta.3-adrenergic," introduces .beta.3-adrenergic agonists that are effective in treating elevated intraocular pressure and glaucoma. These inventions highlight Dubnick's commitment to advancing medical treatments.
Career Highlights
Throughout his career, Bernard Dubnick has been associated with the American Cyanamid Company, where he has contributed to various research initiatives. His work has been instrumental in developing new therapeutic approaches for eye care, showcasing his expertise and dedication to innovation in the medical field.
Collaborations
One of Dubnick's notable collaborators is Romulus K Brazzell. Their partnership has likely fostered a creative environment that encourages the development of groundbreaking solutions in ophthalmology.
Conclusion
Bernard Dubnick's contributions to the field of glaucoma treatment through his patents and collaborations demonstrate his significant impact on medical innovation. His work continues to pave the way for advancements in eye care, benefiting countless patients.